









Markets
/
Stocks
/
nasdaq-lnsr
/

LENSAR Inc

LNSR

12.380USD

-0.020-0.16%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

147.73MMarket Cap

LossP/E TTM



LENSAR Inc

12.380

-0.020-0.16%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

87 / 207

Overall Ranking

194 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Hold

Current Rating

15.000

Target Price

+20.97%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 51.29% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 53.49M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 57.70.

Fairly Valued

The company’s latest PE is -2.95, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 7.77M shares, increasing 4.23% quarter-over-quarter.

Held by Brandes Investmen

Star Investor Brandes Investmen holds 563.58K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.07.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.53, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 13.94M, representing a year-over-year increase of 10.28%, while its net profit experienced a year-over-year increase of 80.49%.

Score

Industry at a Glance

Previous score

6.53

Change



Financials

4.59

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.32

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

5.99

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.63

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -2.95, which is -33.12% below the recent high of -1.97 and -11.10% above the recent low of -3.28.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 87/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for LENSAR Inc is 15.00, with a high of 15.00 and a low of 15.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Hold

Current Rating

15.000

Target Price

+20.97%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

LENSAR Inc

LNSR

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 8.75, which is higher than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 13.04 and the support level at 11.68, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.75

Change

-0.03

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.094

Neutral

RSI(14)

48.169

Neutral

STOCH(KDJ)(9,3,3)

53.471

Sell

ATR(14)

0.336

Low Volatility

CCI(14)

29.740

Neutral

Williams %R

36.585

Buy

TRIX(12,20)

-0.122

Sell

StochRSI(14)

13.154

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

12.428

Sell

MA10

12.341

Buy

MA20

12.346

Buy

MA50

12.690

Sell

MA100

13.012

Sell

MA200

12.090

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 65.87%, representing a quarter-over-quarter increase of 3.42%. The largest institutional shareholder is Brandes Investmen, holding a total of 563.58K shares, representing 4.72% of shares outstanding, with 12.47% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

North Run Capital, LP

1.10M

Curtis (Nicholas T)

792.29K

Brandes Investment Partners, L.P.

Star Investors

544.69K

+11.32%

Link (William J)

550.64K

+1.36%

BlackRock Institutional Trust Company, N.A.

151.82K

-0.49%

The Vanguard Group, Inc.

Star Investors

442.50K

+2.08%

Connaughton (Alan B.)

279.22K

La Française AM

126.00K

Lindstrom (Richard L)

246.41K

+3.08%

Tudor Investment Corporation

Star Investors

277.00K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 5.36, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.49. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.